Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Midwest Professional Planners LTD.

Midwest Professional Planners LTD. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,033 shares of the medical equipment provider’s stock after purchasing an additional 100 shares during the quarter. Midwest Professional Planners LTD.’s holdings in Intuitive Surgical were worth $1,583,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $82,517,000. Sycomore Asset Management raised its stake in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC raised its stake in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its stake in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 22,209 shares of company stock worth $11,928,127 over the last three months. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. CICC Research began coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Evercore ISI raised their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Raymond James lifted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, Piper Sandler reissued an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $476.78 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market cap of $169.82 billion, a PE ratio of 74.38, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The stock’s 50 day moving average price is $568.47 and its 200 day moving average price is $531.22.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.